HurwitzN, RadakovicR, BoyceE, et al.Prevalence of pain in amyotrophic lateral sclerosis: A systematic review and meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener, 2021; 22(7–8):449–458.
KaramCY, PaganoniS, JoyceN, et al.Palliative care issues in amyotrophic lateral sclerosis: An evidence-based review. Am J Hosp Palliat Care, 2016; 33(1):84–92.
4.
NgJ, KhanF, YoungCA, et al.Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease (Review). Cochrane Database Syst Rev, 2017(1):CD011776.
5.
AntmannD, WeydtP, JohnsonKL, et al.Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care, 2004; 21(2):95–104.
6.
WeissMD, MacklinEA, SimmonsZ, et al.A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression. Neurology, 2016; 86(16):1474–1481.
7.
BrettschneiderJ, KurentJ, LudolphA.Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease (Review). Cochrane Database Syst Rev, 2013(6):CD005226.
8.
O'BrienT, KellyM, SaundersC. Motor neurone disease: A hospice perspective. BMJ, 1992; 304(6825):471–473.
